- Home
- PMT vs CRMD Comparison
PMT vs CRMD Comparison
Compare PMT & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMT
- CRMD
- Stock Information
- Founded
- PMT 2009
- CRMD 2006
- Country
- PMT United States
- CRMD United States
- Employees
- PMT N/A
- CRMD N/A
- Industry
- PMT Real Estate Investment Trusts
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- PMT Real Estate
- CRMD Health Care
- Exchange
- PMT Nasdaq
- CRMD Nasdaq
- Market Cap
- PMT 1.1B
- CRMD 973.3M
- IPO Year
- PMT 2009
- CRMD 2010
- Fundamental
- Price
- PMT $13.00
- CRMD $11.88
- Analyst Decision
- PMT Buy
- CRMD Strong Buy
- Analyst Count
- PMT 9
- CRMD 7
- Target Price
- PMT $14.75
- CRMD $17.33
- AVG Volume (30 Days)
- PMT 701.6K
- CRMD 2.4M
- Earning Date
- PMT 07-22-2025
- CRMD 08-13-2025
- Dividend Yield
- PMT 12.31%
- CRMD N/A
- EPS Growth
- PMT N/A
- CRMD N/A
- EPS
- PMT 0.86
- CRMD 0.28
- Revenue
- PMT $591,251,000.00
- CRMD $82,553,827.00
- Revenue This Year
- PMT N/A
- CRMD $238.38
- Revenue Next Year
- PMT $15.69
- CRMD $53.52
- P/E Ratio
- PMT $15.12
- CRMD $42.69
- Revenue Growth
- PMT N/A
- CRMD N/A
- 52 Week Low
- PMT $11.77
- CRMD $3.61
- 52 Week High
- PMT $14.98
- CRMD $17.43
- Technical
- Relative Strength Index (RSI)
- PMT 57.06
- CRMD 41.24
- Support Level
- PMT $12.25
- CRMD $12.14
- Resistance Level
- PMT $12.94
- CRMD $17.43
- Average True Range (ATR)
- PMT 0.21
- CRMD 0.75
- MACD
- PMT 0.06
- CRMD -0.42
- Stochastic Oscillator
- PMT 88.89
- CRMD 0.55
About PMT PennyMac Mortgage Investment Trust of Beneficial Interest
PennyMac Mortgage Investment Trust is a specialty finance company that invests primarily in residential mortgage loans and mortgage-related assets. The company's operations include activities such as the production and servicing of financial securities based on residential loans and the pooling and reselling of high-credit-quality mortgages. The company operates through three segments: correspondent production, credit-sensitive strategies, interest-rate-sensitive strategies. The Credit sensitive strategies segment generates income via investments in CRT arrangements, subordinate MBS, distressed loans, and real estate.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.